STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $715,000 | -83.8% | 44,524 | -84.5% | 0.01% | -86.5% |
| Q1 2018 | $4,404,000 | -55.4% | 287,827 | -54.6% | 0.04% | -57.0% |
| Q4 2017 | $9,883,000 | +40.5% | 633,497 | 0.0% | 0.09% | +50.9% |
| Q3 2017 | $7,032,000 | +20.7% | 633,497 | 0.0% | 0.06% | +11.8% |
| Q2 2017 | $5,828,000 | +7.6% | 633,497 | 0.0% | 0.05% | +15.9% |
| Q1 2017 | $5,416,000 | +51.8% | 633,497 | +90.0% | 0.04% | +25.7% |
| Q4 2016 | $3,568,000 | -1.2% | 333,497 | 0.0% | 0.04% | +6.1% |
| Q3 2016 | $3,612,000 | +60.0% | 333,497 | 0.0% | 0.03% | +37.5% |
| Q2 2016 | $2,258,000 | +45.3% | 333,497 | 0.0% | 0.02% | +50.0% |
| Q1 2016 | $1,554,000 | -26.1% | 333,497 | 0.0% | 0.02% | -5.9% |
| Q4 2015 | $2,104,000 | -28.6% | 333,497 | 0.0% | 0.02% | -37.0% |
| Q3 2015 | $2,945,000 | -25.0% | 333,497 | 0.0% | 0.03% | -20.6% |
| Q2 2015 | $3,925,000 | -18.7% | 333,497 | 0.0% | 0.03% | -15.0% |
| Q1 2015 | $4,826,000 | -16.5% | 333,497 | -1.5% | 0.04% | -32.2% |
| Q4 2014 | $5,778,000 | +36.9% | 338,671 | 0.0% | 0.06% | +11.3% |
| Q3 2014 | $4,220,000 | -15.1% | 338,671 | 0.0% | 0.05% | -13.1% |
| Q2 2014 | $4,968,000 | -27.9% | 338,671 | 0.0% | 0.06% | -30.7% |
| Q1 2014 | $6,895,000 | -47.9% | 338,671 | -49.8% | 0.09% | -52.7% |
| Q4 2013 | $13,231,000 | -63.5% | 675,042 | -15.7% | 0.19% | -63.9% |
| Q3 2013 | $36,255,000 | +69.0% | 800,400 | -11.1% | 0.52% | +21.5% |
| Q2 2013 | $21,456,000 | – | 900,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|